Acute myeloid leukemia, monoallelic CEBPA gene mutation is a type of blood cancer that is defined by a mutation in only one copy of the CEBPA gene. The CEBPA gene is important in helping the body make and regulate blood cells. In this condition, the presence of a mutation in one allele is the key feature that distinguishes it from other forms of leukemia. The condition is identified by this specific chromosomal anomaly. Although this summary focuses on the genetic aspect of the disease, further information is needed to understand the full impact on blood cell production and overall health. Ongoing efforts in the medical field aim to better understand how this single gene mutation affects the disease process.

Information about symptoms is currently limited for this condition.

This form of acute myeloid leukemia is characterized by a mutation in just one allele of the CEBPA gene. This genetic change is the primary factor identified in the condition. Further details about other risk factors or causes are currently limited.